Clinical application of the 70-gene profile: the MINDACT trial
- PMID: 18258980
- DOI: 10.1200/JCO.2007.14.3222
Clinical application of the 70-gene profile: the MINDACT trial
Abstract
The 70-gene profile is a new prognostic tool that has the potential to greatly improve risk assessment and treatment decision making for early breast cancer. Its prospective validation is currently ongoing through the MINDACT (Microarray in Node-Negative Disease May Avoid Chemotherapy) trial, a 6,000-patient randomized, multicentric trial. This article reviews the several steps in the development of the profile from its discovery to its clinical validation.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical